Coagulation Assays

Our Coagulation Testing 

  • aPTT assay (PathromtinSL)
  • Anti FXa assay
  • Protein C neutralising antibody assay
  • PT-INR Assay (ThromborelS)
  • FII activity testing (ThromborelS)
  • FVII activity testing (PathromtinSL)
  • FIX activity testing (PathromtinSL)
  • FX activity testing (ThromborelS)
  • Derived fibrinogen
  • D-Dimer
  • Free Protein S

Understanding coagulation

Coagulation is a complex process that involves the formation of a blood clot in response to injury or damage to blood vessels. The ability to measure coagulation is critical in the diagnosis and management of bleeding disorders and thrombotic disorders. We offer a range of coagulation assays using state-of-the-art technologies and methodologies. Our experienced team of scientists can provide comprehensive analysis of coagulation function. We have extensive experience in the development and validation of bioanalytical assays for drugs targeting the coagulation system, including assays for measuring drug concentrations and assessing drug efficacy and safety. We work closely with our clients to design and validate custom assays that meet guidelines from agencies such as the FDA, EMA and ICH, ensuring that our testing is reliable, accurate, and performed in compliance with regulatory standards.

Improving patient outcomes by supporting innovative therapies

Our drug testing services for bleeding disorders can help to support the development of innovative therapies that improve patient outcomes. Whether you are developing a new drug candidate or need to assess the safety and efficacy of an existing therapy, we can provide the expertise and technology necessary to advance your research. Contact us today to learn more about our drug testing services for bleeding disorders.

Services Overview